Phenotypic and Molecular Identification of Vancomycin Resistance in Clinical Staphylococcus Aureus Isolates in Osogbo, Nigeria

European Journal of Microbiology & Immunology
Bosede Titilope BamigboyeS S Taiwo

Abstract

The use of vancomycin for treatment of serious infections caused by MRSA strains has resulted in emergence of vancomycin-resistant Staphylococcus aureus (VRSA) in clinical settings. Following our previous report of phenotypic VRSA in Nigeria, the current study attempts to determine the genetic basis underlying this resistance. Over a period of 6 months, non-duplicate clinical S. aureus isolates from 73 consecutive patients with infective conditions at Ladoke Akintola University of Technology Teaching Hospital, Osogbo were tested against a panel of eight selected antibiotics by disk diffusion test. The Epsilom test strip was used to determine vancomycin minimum inhibitory concentration (MIC) and polymerase chain reaction (PCR) assay to amplify nuc, mecA, vanA, and vanB genes. Of 73 isolates, 61 (83.6%) had MIC of ≤2 μg/ml, 11 (15.1%) had 4-8 μg/ml and 1 (1.4%) had 16 μg/ml. The mecA gene was detected in 5 (6.8%) isolates but none contained vanA or vanB genes. Both vancomycin-susceptible and intermediate isolates were resistant to multiple antibiotics, while the only vancomycin resistant isolate was resistant to all eight antibiotics. The result confirms the occurrence of phenotypic vancomycin intermediate-resistant S. aureus (VI...Continue Reading

References

Jul 21, 1988·The New England Journal of Medicine·R LeclercqP Courvalin
Oct 1, 1996·Trends in Microbiology·M ArthurP Courvalin
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
Jan 9, 2003·Journal of Clinical Microbiology·Longzhu CuiKeiichi Hiramatsu
May 6, 2005·Journal of Clinical Microbiology·Nottasorn PlipatRichard B Thomson
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred C Tenover, Robert C Moellering
Jun 21, 2008·Journal of Medical Microbiology·G A MenezesS C Parija
Aug 8, 2008·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Marzieh AligholiHossein Sedaght
Nov 22, 2008·Annals of Tropical Paediatrics·R NantandaJ K Tumwine
May 6, 2009·Journal of the Indian Society of Pedodontics and Preventive Dentistry·Kanika Singh Dhull, B Nandlal
Jun 10, 2009·Antimicrobial Agents and Chemotherapy·Bruno Périchon, Patrice Courvalin
Jun 25, 2013·Lancet·José Melo-CristinoMário Ramirez
Aug 31, 2013·Infection and Drug Resistance·Olugbenga Adekunle OloweOyebode Terry Alli
Oct 26, 2013·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Jaciane Baggiotto MarquesRoberto Christ Vianna Santos

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Electrophoresis

Software Mentioned

GraphPad
Window

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Yasmeen TajShahana Urooj Kazmi
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Zulfiqar Ali Mirani, Nusrat Jamil
© 2022 Meta ULC. All rights reserved